StockData
Linde PLC logo

Linde PLC (LIN) stock analysis

LINNasdaqIndustrial Inorganic ChemicalsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 14/3026% above fair value
$526.55+4.77 (+0.91%)

Close on Nov 11, 2026Market cap $241.73BP/E 35.0Yield 1.14%

StockData Score

Prices as of Nov 11, 2026How the score works

Value0Growth2Performance5Health3Dividend4

Mixed14 of 30 checks passed

Linde passes 14 of the 30 checks behind our score. Each dot in the shape is one check — hover it for the numbers.

Valuation
0/6
Growth
2/6
Past performance
5/6
Financial health
3/6
Dividend
4/6

What stands out

  • Return on capital over 10%

    Return on invested capital was 11.5%, above the 10% that usually covers the cost of capital.

  • Earnings grew over 5 years

    Net income grew 22.5% a year on average over the last five fiscal years.

  • EPS growing 10%+ a year

    Diluted EPS grew 21.1% a year over the last three fiscal years.

  • Interest well covered

    Operating income covers interest expense 35.5 times.

What to watch

  • Margin of safety under 20%

    The price is 26.2% above fair value, so there is no margin of safety.

  • Trading above fair value

    The share price of $526.55 is above our fair value estimate of $417.12.

  • Return on equity under 15%

    Return on equity was 18.0% over the last twelve months and averaged 13.7% over five years; we look for 15% on both.

  • High debt

    Debt is 67.7% of shareholders' equity, above the 40% we consider low.

Valuation0/6
  • P/E above its 5-year median

    Linde's P/E of 35.0 is above its own 5-year median of 34.5.

  • P/E above the industry

    Linde's P/E of 35.0 is above the Chemicals and Allied Products median of 25.2.

  • EV/EBITDA above its 5-year median

    Linde's EV/EBITDA of 20.5 is above its 5-year median of 19.3.

  • P/B above the industry

    Linde's price-to-book of 6.13 is above the Chemicals and Allied Products median of 1.25.

  • Trading above fair value

    The share price of $526.55 is above our fair value estimate of $417.12.

  • Margin of safety under 20%

    The price is 26.2% above fair value, so there is no margin of safety.

Growth2/6
  • Revenue growing under 10% a year

    Revenue grew 0.6% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growing 10%+ a year

    Diluted EPS grew 21.1% a year over the last three fiscal years.

  • Earnings growth not accelerating

    Net income grew -1.2% over the last twelve months, against a 5-year average of 22.5% a year.

  • Growing slower than the industry

    Revenue grew 8.2% over the last twelve months; the Chemicals and Allied Products median is 8.2%.

  • Guidance raised

    Linde raised its Full-year capital expenditures outlook on Jul 31, 2026.

  • Gross margin slipping

    Gross margin was 47.9% over the last twelve months, against 48.8% a year earlier.

Past performance5/6
  • Return on equity under 15%

    Return on equity was 18.0% over the last twelve months and averaged 13.7% over five years; we look for 15% on both.

  • Return on capital over 10%

    Return on invested capital was 11.5%, above the 10% that usually covers the cost of capital.

  • Return on equity above the industry

    Linde's return on equity of 18.0% is above the Chemicals and Allied Products median of -0.8%.

  • Earnings grew over 5 years

    Net income grew 22.5% a year on average over the last five fiscal years.

  • Net margin above its 5-year average

    Net margin was 19.3% over the last twelve months, against a 5-year average of 16.8%.

  • Net margin above the industry

    Linde's net margin of 19.3% is above the Chemicals and Allied Products median of -0.4%.

Financial health3/6
  • High debt

    Debt is 67.7% of shareholders' equity, above the 40% we consider low.

  • Debt rising against equity

    Debt to equity rose from 34.1% five years ago to 67.7%.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 40.1% of total debt.

  • Interest well covered

    Operating income covers interest expense 35.5 times.

  • Short-term assets don't cover short-term debts

    Current assets are 0.86 times current liabilities.

  • Low bankruptcy risk

    The Altman Z-score is 4.12; above 3 is the safe zone and below 1.8 the distress zone.

Dividend4/6
  • Pays a dividend

    Linde paid dividends worth 1.2% of the share price over the last twelve months.

  • Yield below Treasuries

    The 1.2% yield is below the 4.4% on a 1-year Treasury.

  • Yield below the top quarter

    The top quarter of US dividend payers yield 3.8% or more; Linde yields 1.2%.

  • Dividend not cut

    The dividend per share has not fallen by more than 10% in any of the last 10 fiscal years.

  • Covered by earnings

    Dividends take 41.6% of net income.

  • Covered by free cash flow

    Dividends take 57.3% of free cash flow.

Scores of similar companies

Our estimate per share

$417.12

The share price is 26% above this estimate.

20%+ below
Near fair value
20%+ above
$526.55Price$417.12Fair value
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E29.9×34.5×25.2×$450.3040%
EV/EBITDA20.3×19.3×21.4×$526.0235%
P/B3.3×5.3×1.2×$281.2910%
Earnings power7.8% cost of equity––$165.1115%
Fair value$417.12100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 34.5
  • Chemicals and Allied Products median 25.2

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$1.08B
Value traded per 1% price move
$1.29B

Downside

Low risk

Typical loss in a bad month
8.4%
Volatility (annualized)
19%
Sharpe ratio, 1 year
1.10
Beta to the S&P 500 (5Y)
0.58

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2015 to 2025

Gross margin

48.8%+5.3 pts over 5 years

Operating margin

26.3%+14.1 pts over 5 years

Net margin

20.3%+11.1 pts over 5 years

See a number that looks wrong?